Jiang, Z.; Bi, F.; Ge, Z.; Mansolf, M.; Hartwich, T.M.P.; Kolesnyk, V.; Yang, K.; Park, W.; Kim, D.; Grechukhina, O.;
et al. SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer. Cancers 2025, 17, 244.
https://doi.org/10.3390/cancers17020244
AMA Style
Jiang Z, Bi F, Ge Z, Mansolf M, Hartwich TMP, Kolesnyk V, Yang K, Park W, Kim D, Grechukhina O,
et al. SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer. Cancers. 2025; 17(2):244.
https://doi.org/10.3390/cancers17020244
Chicago/Turabian Style
Jiang, Ziyan, Fangfang Bi, Zhiping Ge, Miranda Mansolf, Tobias M. P. Hartwich, Viktoriia Kolesnyk, Kevin Yang, Wonmin Park, Dongin Kim, Olga Grechukhina,
and et al. 2025. "SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer" Cancers 17, no. 2: 244.
https://doi.org/10.3390/cancers17020244
APA Style
Jiang, Z., Bi, F., Ge, Z., Mansolf, M., Hartwich, T. M. P., Kolesnyk, V., Yang, K., Park, W., Kim, D., Grechukhina, O., Hui, P., Kim, S. W., & Yang-Hartwich, Y.
(2025). SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer. Cancers, 17(2), 244.
https://doi.org/10.3390/cancers17020244